Gujwell Biotech Private Limited
Gujwell Biotech Private Limited is a Private Non-govt company company incorporated in 2011 and based in Gujarat, India. Gujwell Biotech Private Limited operates in Pharmaceuticals & Chemicals (NIC 24129) with authorized capital of ₹30.00 L and paid-up capital of ₹20.00 L. For 2020-21, the company reported revenue of ₹1.59 Cr and a net loss of ₹25.37 L. RegisterKaro's provisional Compliance Health Score for the company is 67/100 (grade C), based on 4 of 9 signals — full scoring is pending extraction of the company's MCA filing history.
GUJWELL BIOTECH PRIVATE LIMITED is the legal entity of Gujwell Biotech.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Gujwell Biotech Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +35d | filed |
| MGT-7 | FY2024-25 | 22 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 24 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 24 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Gujwell Biotech Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 281048299 | Axis Bank Ltd(Bank) | ₹12.05 Cr | 19 Sep 2019 | Open |
| 626890566 | Axis Bank Ltd(Bank) | ₹1.05 Cr | 04 Jul 2022 | Open |
| 915431121 | Kotak Mahindra Bank Ltd(Bank) | ₹18.54 Cr | 27 Jan 2022 | Open |
| 619036475 | Axis Bank Ltd(Bank) | ₹2.05 Cr | 19 Sep 2023 | Open |
Charge IDs, lenders & amounts for Gujwell Biotech Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2020-21 | — | ||||
| 2018-19 | — | ||||
| 2017-18 | — | ||||
| 2016-17 | — |
Detailed Financials
4 FYs| Line item | 2020-21 | 2018-19 | 2017-18 | 2016-17 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue from operations | ||||
| Other income | ||||
| Total income | ||||
| Total expenses | ||||
| Profit before tax | ||||
| Profit / (Loss) after tax | ||||
| Balance sheet | ||||
| Equity / Net worth | ||||
| Borrowings | ||||
| Current liabilities | ||||
| Total liabilities | ||||
| Current assets | ||||
| Cash & equivalents | ||||
| Total assets | ||||
| Employees | — | — | — | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue2020-21 | -12.0% | -53.0% | — | |
| Profit after Tax2020-21 | -8291.0% | — | — | |
| Net Worth2020-21 | -95.0% | -76.0% | — |
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2016-17 | +0.08% | — | +1.63% | +0.17% | 9.58 | |||
| 2017-18 | +0.15% | -43.58% | — | +0.27% | — | |||
| 2018-19 | +0.13% | -40.72% | +0.80% | +0.10% | 8.15 | |||
| 2020-21 | -15.95% | -49.60% | -106.77% | -7.92% | 13.48 |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 3 | 1,89,53,117 | 72.20% |
| Institutional Investors | 3 | 33,51,352 | 12.77% |
| Public & Others | 52 | 39,45,771 | 15.03% |
Promoter, institutional & public holding for Gujwell Biotech Private Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
129 peersEvents & timeline
2External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.